Drugs / Arnovie101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07629596 | Apr 2026 → May 2027 expected | autoimmune hemolytic anemia, systemic lupus erythematosus | Circunited BioPharma (Shenzhen) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arnovie101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07629596 ↗ |
| Route | Intravenous | “Arnovie101 Infusion Intravenous” NCT07629596 ↗ |